CSBR vs MCD · P/E 16, rev $56.9M vs P/E 23, rev $25.92B
Champions Oncology Inc (CSBR) versus McDonald’s Corporation (MCD) — a side-by-side from cached financials, not a winner call.
Champions Oncology Inc (CSBR) is a biotechnology company listed on US.
McDonald’s Corporation (MCD) is a restaurants company listed on NYSE. It is led by Chris Kempczinski.
Latest reported CSBR revenue for 2025-04-30 was $56.9M. Net income was $4.7M. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
Latest reported MCD revenue for 2024-12-31 was $25.92B. Net income was $8.22B. Revenue was up 1.7% from 2023-12-31 to 2024-12-31. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
CSBR currently screens at market cap $99.8M and trailing P/E 16.0. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
Not investment advice. Open the CSBR and MCD stock pages for the full models.
Not investment advice.